Why the study?
Does ELN hemizygosity cause compensatory structural changes in arterial development in mice and humans?
Does ELN hemizygosity cause compensatory structural changes in arterial development in mice and humans?
ELN hemizygosity induces a compensatory increase in elastic lamellae and smooth muscle during arterial development, explaining the profound arterial thickening and risk of obstructive vascular disease in affected humans.
Answers are grounded in this paper and cite their sources.
May account for stenosis risk in ELN disorders; leaves open targeted validation in humans.
Obstructive vascular disease is an important health problem in the industrialized world. Through a series of molecular genetic studies, we demonstrated that loss-of-function mutations in one elastin allele cause an inherited obstructive arterial disease, supravalvular aortic stenosis (SVAS). To define the mechanism of elastin's effect, we generated mice hemizygous for the elastin gene (ELN +/-). Although ELN mRNA and protein were reduced by 50% in ELN +/- mice, arterial compliance at physiologic pressures was nearly normal. This discrepancy was explained by a paradoxical increase of 35% in the number of elastic lamellae and smooth muscle in ELN +/- arteries. Examination of humans with ELN hemizygosity revealed a 2. 5-fold increase in elastic lamellae and smooth muscle. Thus, ELN hemizygosity in mice and humans induces a compensatory increase in the number of rings of elastic lamellae and smooth muscle during arterial development. Humans are exquisitely sensitive to reduced ELN expression, developing profound arterial thickening and markedly increased risk of obstructive vascular disease.
No takes yet. Share an insight, caveat, or question.
Li et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: